Skip to main content

Table 4 Measures results obtained before and after the two different cardiac rehabilitation programs

From: Effectiveness and safety of a home-based cardiac rehabilitation programme of mixed surveillance in patients with ischemic heart disease at moderate cardiovascular risk: A randomised, controlled clinical trial

 

Hospital based cardiac rehabilitation program

Home based cardiac rehabilitation program

p-valuea

p-valueb

Before

After

Before

After

METS

7.10 (1.97)

8.45 (1.71)

7.55 (2.77)

8.28 (2.62)

0.03*

0.49

Exercise time (min)

5.47 (2.08)

6.87 (1.67)

5.84 (2.66)

6.38 (1.80)

0.03*

0.32

Heart rate maximal (bpm)

132.84 (16.11)

123.38 (17.38)

107.23 (32.58)

123.84 (22.61)

-

0.009**

% of predicted peak HR.

79.86 (12.27)

75.16 (9.2)

65.10 (20.09)

75.81 (14.07)

.

0.008**

Borg Scale

12.57 (1.15)

13.57 (1.22)

13.07 (1.49)

13.69 (1.18)

0.015*

0.54

Recovery rate 1 min (bpm)

13.85 (5.02)

17.21 (6.29)

11.63 (7.41)

13.81 (4.46)

0.008**

0.54

BMI (kg/m2)

29.29 (3.62)

29.08 (37.6)

28.60 (3.80)

29.08 (4.33)

0.54

0.13

Waist-hip ratio (cm)

106.42 (8.84)

105.35 (9.96)

103.84 (10.56)

103.69 (10.59)

0.24

0.37

Total cholesterol (mg/dL)

130.50 (32.16)

138.21 (25.41)

142.66 (29.44)

135.91 (23.43)

0.91

0.10

HDL cholesterol (mg/dL)

37.85 (8.07)

20.57 (8.75)

39.45 (8.99)

40.45 (7.01)

0.24

0.58

LDL cholesterol (mg/dL)

62.17 (23.19)

68.62 (16.63)

70.30 (26.14)

61.13 (15.50)

0.74

0.06

Triglycerides (mg/dL)

161.21 (72.31)

161.07 (102.20)

149.83 (61.56)

160.08 (84.71)

0.77

0.76

Glucose (mg/dL)

94.92 (13.56)

104.07 (27.73)

109.83 (28.67)

106.75 (14.61)

0.57

0.26

HbA1c

5.62 (1.05)

5.75 (1.30)

6.05 (1.18)

6.15 (1.36)

0.35

0.90

Systolic blood pressure (mm Hg)

115.76 (24.65)

119.23 (19.45)

119.35 (24.05)

120.35 (16.69)

0.65

0.80

Diastolic blood pressure (mm Hg)

69.23 (11.87)

72.30 (11.65)

71.50 (9.48)

72.14 (11.21)

0.45

0.62

SF-36 (score)

53.33 (19.80)

63.63 (21.00)

47.93 (22.57)

43.62 (24.20)

-

0.004**

  1. Data are presented as mean values (SD)
  2. aSignificance level for the hypothesis of no time effect
  3. bSignificance level for the hypothesis of no time x group effect (difference in outcome improvement between the two programs)
  4. *Significance level p < 0.05
  5. **Significance level p < 0.01
  6. Significant values are highlighted in bold